CLOPIXOL

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Germany, Spain, France, Hong Kong, Ireland, Israel, Malta, Mexico, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CLOPIXOL contains one active pharmaceutical ingredient (API):

1 Zuclopenthixol
UNII 47ISU063SG - ZUCLOPENTHIXOL

Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect.

Read about Zuclopenthixol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CLOPIXOL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLOPIXOL Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLOPIXOL ACUPHASE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AF05 Zuclopenthixol N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives
Discover more medicines within N05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8097E
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 524200201114412, 524200202110410, 524200203151412, 524200204156418
Country: CA Health Products and Food Branch Identifier(s): 02230402, 02230403, 02230405, 02230406
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01125028, 01177930, 02522056, 02752543, 02752566, 03569634, 06585384, 06729469, 09102802, 09321792, 10930740, 13713552, 14136051, 14236605, 15266318, 17562908
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60871, 60872, 60873, 60874, 60875
Country: FR Base de données publique des médicaments Identifier(s): 60209937, 61323662, 62788550, 63744998, 68072846, 69974746
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 147150, 147160, 198691, 24633, 24634, 24635, 27619, 27629, 377428, 399365, 41302
Country: HK Department of Health Drug Office Identifier(s): 19861, 22761
Country: IE Health Products Regulatory Authority Identifier(s): 17841, 17914, 18139
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2426, 623, 624, 626, 627, 628, 629, 630, 6787, 6788, 6789, 6790
Country: MT Medicines Authority Identifier(s): AA565/28903, MA1323/00101
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 414M96, 415M96, 417M96
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 5434, 5435, 5436
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100015033, 100015040, 100015056, 100248091
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W10638002, W12431001, W12437002, W12437003, W12439002, W12439003, W13182005
Country: SG Health Sciences Authority Identifier(s): 01365P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699795090505, 8699795091335, 8699795091342, 8699795590012, 8699795750201, 8699795750225
Country: ZA Health Products Regulatory Authority Identifier(s): R/2.6.5/52, T/2.6.5/180, T/2.6.5/181, W/2.6.5/27

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.